Opioids: Digital Therapeutics
ICER will assess the comparative clinical effectiveness and economic value of digital therapeutics for opioid use disorder. ICER has reviewed other related topics, such as abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, and non-drug interventions for lower back pain.
This review reinforces ICER’s commitment to provide an independent evaluation of the evidence around interventions that target the public health crises stemming from the opioid epidemic in the United States.
Review date: November 2020
For more information, please contact Maggie O’Grady, Program Manager, at email@example.com.
The Midwest CEPAC will convene virtually to deliberate and vote on evidence presented in ICER's report on digital therapeutics for opioid use disorder (OUD).